Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > Gross Margin

Adverum Biotechnlgs Gross Margin Chart (ADVM)

Adverum Biotechnlgs annual/quarterly Gross Margin from 2013 to 2019. Gross margin is a company's total sales revenue minus its cost of goods sold (COGS), divided by total sales revenue, expressed as a percentage. The higher the percentage, the more the company retains on each dollar of sales, to service its other costs and debt obligations.
  • Adverum Biotechnlgs Gross Margin for the quarter ending September 09, 2019 was $-3,878m a 43.90% decrease of -1,702m year over year
  • Adverum Biotechnlgs Gross Margin for the last 12 months ending June 06, 2020 was $-21,998m a 46.68% decrease of -10,268m year over year
  • Adverum Biotechnlgs Annual Gross Margin for 2019 was $-16,068m a 81.27% decrease of -13,058m from 2018
  • Adverum Biotechnlgs Annual Gross Margin for 2018 was $-3,010m a 31.74% decrease of -955m from 2017
  • Adverum Biotechnlgs Annual Gross Margin for 2017 was $-2,055m a 3.61% decrease of -74m from 2016
Other Margins & Efficiency Metrics:
  • Adverum Biotechnlgs EBITDA Margin for the quarter ending March 03, 2013 was $-13m
  • Adverum Biotechnlgs Return on Capital % for the quarter ending September 09, 2018 was -20.57 a -10.43% increase of 2.15 year over year
  • Adverum Biotechnlgs Return on Equity % for the quarter ending September 09, 2018 was -37.34 a 13.20% decrease of -4.93 year over year
View Chart On Koyfin

Quarterly ADVM Gross Margin Data

09/2019$-3,878m
12/2018$-16,531m
09/2018$-1,638m
06/2018$-2,175m
03/2018$-5,823m
12/2017$-2,506m
09/2017$-2,119m
06/2017$-1,734m
03/2017$-1,861m
12/2016$-1,518m

Annual ADVM Gross Margin Data

2019$-16,068m
2018$-3,010m
2017$-2,055m
2016$-1,980m
2015$-998m
2014$-2,868m
2013$-348m
2012$-4,267m